IDrugs. 2007 Jan;10(1):37-41.

New ocular therapeutics: a view from the patenting perspective.

Source

HM Pharma Consultancy, Enenkelstrasse 28/32, A-1160 Wien, Austria. h.mucke@hmpharmacon.com

Abstract

This feature article provides an overview of the newest therapeutic developments for ocular diseases, based on patents and patent applications that were published in the 12-month period from November 2005 to October 2006. In contrast to peer-reviewed literature covering breakthroughs in basic science research, the patenting perspective discloses the intentions of the pharmaceutical industry for imminent drug development. Selected documents describing drug delivery, dry eye syndrome, ocular infections and lesions, glaucoma and age-related macular degeneration are discussed. The role of RNA interference, which is of particular interest in ophthalmology research, is also highlighted.

PMID:: 17187313; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

RNA, Small Interfering

LinkOut - more resources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Eye Diseases - MedlinePlus Health Information

Supplemental Content

Related citations

Review Current ocular drug delivery challenges for N-acetylcarnosine: novel patented routes and modes of delivery, design for enhancement of therapeutic activity and drug delivery relationships. [Recent Pat Drug Deliv Formul. 2009]
Review Current ocular drug delivery challenges for N-acetylcarnosine: novel patented routes and modes of delivery, design for enhancement of therapeutic activity and drug delivery relationships.
Babizhayev MA. Recent Pat Drug Deliv Formul. 2009 Nov; 3(3):229-65.
Review Current drug patenting for retinal diseases: beyond VEGF inhibitors. [IDrugs. 2010]
Review Current drug patenting for retinal diseases: beyond VEGF inhibitors.
Mucke HA, Mucke PM. IDrugs. 2010 Jan; 13(1):30-7.
Review Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. [Am J Ophthalmol. 2006]
Review Evidence for the use of nutritional supplements and herbal medicines in common eye diseases.
West AL, Oren GA, Moroi SE. Am J Ophthalmol. 2006 Jan; 141(1):157-66.
Review Drugs for some common eye disorders. [Treat Guidel Med Lett. 2007]
Review Drugs for some common eye disorders.
. Treat Guidel Med Lett. 2007 Jan; 5(53):1-8.
Drugs for some common eye disorders. [Treat Guidel Med Lett. 2010]
Drugs for some common eye disorders.
. Treat Guidel Med Lett. 2010 Jan; 8(89):1-8; quiz 9-10.

See reviews... See all...

Cited by 1 PubMed Central article

International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics. [Clin Ophthalmol. 2009]
International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics.
Mucke HA, Mucke P, Mucke E. Clin Ophthalmol. 2009; 3:103-9. Epub 2009 Jun 2.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

New ocular therapeutics: a view from the patenting perspective.
New ocular therapeutics: a view from the patenting perspective.
IDrugs. 2007 Jan ;10(1):37-41.

PubMed
Modeling the MHC class I pathway by combining predictions of proteasomal cleavag...
Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding.
Cell Mol Life Sci. 2005 May ;62(9):1025-37.

PubMed
Focus on pain mechanisms and pharmacotherapy in the treatment of fibromyalgia sy...
Focus on pain mechanisms and pharmacotherapy in the treatment of fibromyalgia syndrome.
Clin Exp Rheumatol. 2009 Sep-Oct ;27(5 Suppl 56):S86-91.

PubMed
Role of bacteria in the development of kidney stones.
Role of bacteria in the development of kidney stones.
Curr Opin Urol. 2000 Jan ;10(1):35-8.

PubMed
Antibodypedia, a portal for sharing antibody and antigen validation data.
Antibodypedia, a portal for sharing antibody and antigen validation data.
Mol Cell Proteomics. 2008 Oct ;7(10):2028-37. Epub 2008 Jul 29 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: